Trending - Altmetric
- Repurposing vandetanib plus everolimus for the treatment of ACVR1-mutant diffuse intrinsic pontine gliomaLast mentioned on Fri Sep 24 2021
- Six Month Efficacy and Toxicity Profile of BNT162b2 Vaccine in Cancer Patients with Solid TumorsLast mentioned on Sun Sep 26 2021
- Low Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to ImmunotherapyLast mentioned on Fri Sep 17 2021
- Mobocertinib (TAK-788): A Targeted Inhibitor of EGFR Exon 20 Insertion Mutants in Non–Small Cell Lung CancerLast mentioned on Mon Sep 20 2021
- Mesenchymal Lineage Heterogeneity Underlies Non-Redundant Functions of Pancreatic Cancer-Associated FibroblastsLast mentioned on Fri Sep 24 2021
- Spatiotemporal Immune Landscape of Colorectal Cancer Liver Metastasis at Single-Cell LevelLast mentioned on Thu Sep 09 2021
- SMARCA4 inactivation promotes lineage-specific transformation and early metastatic features in the lungLast mentioned on Mon Sep 27 2021
- Mitochondrial Fragmentation Triggers Ineffective Hematopoiesis in Myelodysplastic SyndromesLast mentioned on Sat Sep 11 2021
- Systematic profiling of DNMT3A variants reveals protein instability mediated by the DCAF8 E3 ubiquitin ligase adaptorLast mentioned on Sat Sep 04 2021
- INK4 tumor suppressor proteins mediate resistance to CDK4/6 kinase inhibitorsLast mentioned on Thu Sep 23 2021
- MYC levels regulate metastatic heterogeneity in pancreatic adenocarcinomaLast mentioned on Sun Sep 26 2021
- WNT as a Driver and Dependency in CancerLast mentioned on Tue Sep 21 2021
- Clonal hematopoiesis: from mechanisms to clinical interventionLast mentioned on Tue Sep 07 2021
- NKX3.1 Localization to Mitochondria Suppresses Prostate Cancer InitiationLast mentioned on Wed Sep 08 2021
- Targeted Therapies for Targeted Populations: Anti-EGFR Treatment for EGFR-Amplified Gastroesophageal AdenocarcinomaLast mentioned on Sun Sep 19 2021
- Discovery and Features of an Alkylating Signature in Colorectal CancerLast mentioned on Mon Sep 27 2021
- Targeting EGFR Exon 20 Insertions in Non–Small Cell Lung Cancer: Recent Advances and Clinical UpdatesLast mentioned on Thu Sep 23 2021
- Dissecting Response and Resistance to Anti–PD-1 Therapy in Microsatellite-Unstable Gastric CancerLast mentioned on Sun Sep 19 2021
- Maturation Stage of T-cell Acute Lymphoblastic Leukemia Determines BCL-2 versus BCL-XL Dependence and Sensitivity to ABT-199Last mentioned on Fri Sep 10 2021
- Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor-Resistant, EGFR-Mutated Non-Small Cell Lung CancerLast mentioned on Fri Sep 24 2021
- Leukocyte Heterogeneity in Pancreatic Ductal Adenocarcinoma: Phenotypic and Spatial Features Associated with Clinical OutcomeLast mentioned on Thu Sep 02 2021
Pages